Literature DB >> 9603457

MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.

G Malcherek1, C Wirblich, N Willcox, H G Rammensee, J Trowsdale, A Melms.   

Abstract

Proteolysis of the invariant chain (li) leads to the generation of abundant MHC class II-associated invariant chain peptides (CLIP), which bind in the MHC class II binding groove via supermotifs in a manner similar to that of antigenic peptides. We have engineered an li vector with the capacity to express any antigenic peptide of interest instead of CLIP, for T cell stimulation. When peripheral blood mononuclear cells (PBMC) were pulsed with li hybrids encoding T cell epitopes of tetanus toxin or acetylcholine receptor, stimulation of T cells was dramatically enhanced compared to stimulation after priming with either the native or recombinant proteins. Site-specific insertion of antigenic sequences into the CLIP region promoted enhanced antigenicity of li hybrids which were shown to be processed intracellularly in a chloroquine-sensitive compartment. Naturally processed T helper epitopes were visualized directly on the surface of PBMC and identified as analogs of CLIP associated with MHC class II molecules. This novel li vector provides a flexible and efficient system for the delivery of defined peptide epitopes to T cells which might be useful in the development of specific vaccines and in the study of intracellular processing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603457     DOI: 10.1002/(SICI)1521-4141(199805)28:05<1524::AID-IMMU1524>3.0.CO;2-T

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.

Authors:  F Bischof; W Wienhold; C Wirblich; G Malcherek; O Zevering; A M Kruisbeek; A Melms
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

Review 2.  Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.

Authors:  Shaw-Wei D Tsen; Augustine H Paik; Chien-Fu Hung; T-C Wu
Journal:  Expert Rev Vaccines       Date:  2007-04       Impact factor: 5.217

3.  DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency.

Authors:  Chien-Fu Hung; Ya-Chea Tsai; Liangmei He; T-C Wu
Journal:  Mol Ther       Date:  2007-03-13       Impact factor: 11.454

4.  MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cells.

Authors:  Courtney L Erskine; Christopher J Krco; Karen E Hedin; Nancy D Borson; Kimberly R Kalli; Marshall D Behrens; Sabrina M Heman-Ackah; Eric von Hofe; Peter J Wettstein; Mansour Mohamadzadeh; Keith L Knutson
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

5.  Induction of protective immunity to Listeria monocytogenes by immunization with plasmid DNA expressing a helper T-cell epitope that replaces the class II-associated invariant chain peptide of the invariant chain.

Authors:  Toshi Nagata; Taiki Aoshi; Mina Suzuki; Masato Uchijima; Yeung-Hyen Kim; Zhibo Yang; Yukio Koide
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.

Authors:  R F Wang; X Wang; S A Rosenberg
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

7.  Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity.

Authors:  Nadia Mensali; Amalie Grenov; Niladri Bhusan Pati; Pierre Dillard; Marit Renée Myhre; Gustav Gaudernack; Gunnar Kvalheim; Else Marit Inderberg; Oddmund Bakke; Sébastien Wälchli
Journal:  Oncoimmunology       Date:  2019-01-11       Impact factor: 8.110

Review 8.  Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome.

Authors:  Jean-Simon Fortin; Maryse Cloutier; Jacques Thibodeau
Journal:  Front Immunol       Date:  2013-12-13       Impact factor: 7.561

9.  Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

Authors:  Alexandra J Spencer; Matthew G Cottingham; Jennifer A Jenks; Rhea J Longley; Stefania Capone; Stefano Colloca; Antonella Folgori; Riccardo Cortese; Alfredo Nicosia; Migena Bregu; Adrian V S Hill
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

10.  Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8+ T Cell Responses.

Authors:  Benedict R Halbroth; Sarah Sebastian; Hazel C Poyntz; Migena Bregu; Matthew G Cottingham; Adrian V S Hill; Alexandra J Spencer
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.